FFR与血管造影在多支血管疾病患者中的临床结局和成本效益分析

数据集获取（Figshare）

• 源站标题：Clinical Outcomes and Cost-Effectiveness Analysis of FFR Compared with Angiography in Multivessel Disease Patient
• DOI：10.6084/m9.figshare.7676513.v1
• 发布日期：2019-02-06
• 文件数：8 个
• 文件总体积：312.16 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Clinical_Outcomes_and_Cost-Effectiveness_Analysis_of_FFR_Compared_with_Angiography_in_Multivessel_Disease_Patient/7676513

命令行下载

curl -L -o "0066-782X-abc-20180262-gf01.jpg" "https://ndownloader.figshare.com/files/14262353"
curl -L -o "0066-782X-abc-20180262-gf02.jpg" "https://ndownloader.figshare.com/files/14262356"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/14262359"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/14262362"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/14262365"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/14262368"
curl -L -o "Table_5.xls" "https://ndownloader.figshare.com/files/14262371"
curl -L -o "Table_6.xls" "https://ndownloader.figshare.com/files/14262374"

文件清单

• 0066-782X-abc-20180262-gf01.jpg（162.38 KB）
• 0066-782X-abc-20180262-gf02.jpg（115.98 KB）
• Table_1.xls（5.63 KB）
• Table_2.xls（5.63 KB）
• Table_3.xls（5.63 KB）
• Table_4.xls（5.63 KB）
• Table_5.xls（5.63 KB）
• Table_6.xls（5.63 KB）

文件总体积 312.16 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract Background: In multivessel disease patients with moderate stenosis, fractional flow reserve (FFR) allows the analysis of the lesions and guides treatment, and could contribute to the cost-effectiveness (CE) of non-pharmacological stents (NPS). Objectives: To evaluate CE and clinical impact of FFR-guided versus angiography-guided angioplasty (ANGIO) in multivessel patients using NPS. Methods: Multivessel disease patients were prospectively randomized to FFR or ANGIO groups during a 5 year-period and followed for < 12 months. Outcomes measures were major adverse cardiac events (MACE), restenosis and CE. Results: We studied 69 patients, 47 (68.1%) men, aged 62.0 ± 9.0 years, 34 (49.2%) in FFR group and 53 (50.7%) in ANGIO group, with stable angina or acute coronary syndrome. In FFR, there were 26 patients with biarterial disease (76.5%) and 8 (23.5%) with triarterial disease, and in ANGIO, 24 (68.6%) with biarterial and 11 (31.4%) with triarterial disease. Twelve MACEs were observed - 3 deaths: 2 (5.8%) in FFR and 1 (2.8%) in ANGIO, 9 (13.0%) angina: 4(11.7%) in FFR and 5(14.2%) in ANGIO, 6 restenosis: 2(5.8%) in FFR and 4 (11.4%) in ANGIO. Angiography detected 87(53.0%) lesions in FFR, 39(23.7%) with PCI and 48(29.3%) with medical treatment; and 77 (47.0%) lesions in ANGIO, all treated with angioplasty. Thirty-nine (33.3%) stents were registered in FFR (0.45 ± 0.50 stents/lesion) and 78 (1.05 ± 0.22 stents/lesion) in ANGIO (p = 0.0001), 51.4% greater in ANGIO than FFR. CE analysis revealed a cost of BRL 5,045.97 BRL 5,430.60 in ANGIO and FFR, respectively. The difference of effectiveness was of 1.82%. Conclusion: FFR reduced the number of lesions treated and stents, and the need for target-lesion revascularization, with a CE comparable with that of angiography.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.7676513.v1（source: https://scielo.figshare.com/articles/dataset/Clinical_Outcomes_and_Cost-Effectiveness_Analysis_of_FFR_Compared_with_Angiography_in_Multivessel_Disease_Patient/7676513）。